(Q47351539)

14 January 2018

title

Ideal rather than actual body weight should be used to calculate cell dose in allogeneic hematopoietic stem cell transplantation (English)

1 reference

14 January 2018

author

Leo Gordon

2

1 reference

14 January 2018

author name string

Singhal S

1

1 reference

14 January 2018

Tallman MS

3

1 reference

14 January 2018

Winter JN

4

1 reference

14 January 2018

Evens AM

5

1 reference

14 January 2018

Frankfurt O

6

1 reference

14 January 2018

Williams SF

7

1 reference

14 January 2018

Grinblatt D

8

1 reference

14 January 2018

Kaminer L

9

1 reference

14 January 2018

Meagher R

10

1 reference

14 January 2018

Mehta J

11

1 reference

14 January 2018

language of work or name

English

0 references

publication date

1 March 2006

1 reference

14 January 2018

Bone Marrow Transplantation

published in

1 reference

14 January 2018

volume

37

1 reference

14 January 2018

issue

6

1 reference

14 January 2018

page(s)

553-557

1 reference

14 January 2018

melphalan, single-fraction total-body irradiation and allogeneic bone marrow transplantation for acute leukemia: review of transplant-related mortality

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Comparison of autologous peripheral blood stem cell dosing by ideal vs actual body weight.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Ideal or actual body weight to calculate CD34+ cell doses for autologous hematopoietic stem cell transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Ideal or actual body weight to calculate CD34+ cell doses for allogeneic hematopoietic stem cell transplantation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Clinical Pharmacy: Case Studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Chronic graft-versus-host disease after allogeneic blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

CD34 cell dose in granulocyte colony-stimulating factor-mobilized peripheral blood mononuclear cell grafts affects engraftment kinetics and development of extensive chronic graft-versus-host disease after human leukocyte antigen-identical sibling tr

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

Death by graft-versus-host disease associated with HLA mismatch, high recipient age, low marrow cell dose, and splenectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

7 January 2021

A low CD34+ cell dose results in higher mortality and poorer survival after blood or marrow stem cell transplantation from HLA-identical siblings: should 2 x 10(6) CD34+ cells/kg be considered the minimum threshold?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

7 January 2021

Allogeneic transplantation of CD34(+) selected cells from peripheral blood from human leukocyte antigen-identical siblings: detrimental effect of a high number of donor CD34(+) cells?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

7 January 2021

Early identification of patients at risk of death due to infections, hemorrhage, or graft failure after allogeneic bone marrow transplantation on the basis of the leukocyte counts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.BMT.1705282

7 January 2021

Identifiers

DOI

10.1038/SJ.BMT.1705282

1 reference

14 January 2018

1 reference

14 January 2018